Anophthalmos

Back

Practice Essentials

Anophthalmia can be challenging to treat. Patients with anophthalmia often require a team of specialists for proper care. Considerations include identifying associated abnormalities (eg, microcephalia) that may present additional risks to the patient. Aesthetics and cosmesis are important to the self-esteem of the patient. Oculofacial surgery may be costly and may be beyond the reach of many families. Long-term follow-up of the patient is necessary for maximizing his or her function and self-esteem.

Background

True or primary anophthalmos is very rare. Only when there is a complete absence of the ocular tissue within the orbit can a diagnosis of true anophthalmos be made. Extreme microphthalmos is seen more commonly. In this condition, a very small globe is present within the orbital soft tissue, which is not visible on initial examination.

Anophthalmia and microphthalmia may occur secondary to the arrest of development of the eye at various stages of growth of the optic vesicle. It is important to recognize microphthalmia because the development of the orbital region, as well as the lids and the fornices, is dependent on the presence of a normal-sized eye in utero.

Anophthalmia may lead to serious problems in a child due to not only the absence of a seeing eye but also the secondary disfigurement of the orbit, the lids, and the eye socket. Early treatment with various expanders or surgery, when necessary, will help decrease the orbital asymmetry and cosmetic deformities in these children.

See the clinical images below:



View Image

Anophthalmic socket (left eye).



View Image

Close-up view of anophthalmic socket (left eye).

Pathophysiology

Anophthalmia occurs when the neuroectoderm of the primary optic vesicle fails to develop properly from the anterior neural plate of the neural tube during embryological development. The more commonly seen microphthalmia can result from a problem in development of the globe at any stage of growth of the optic vesicle.

The most common genetic disturbance associated with anophthalmia and microphthalmia is de novo loss of function mutations in the SOX2 gene.[1] In consanguineous families, the gene ALDH1A3 may also play an important role.[2]

Proper growth of the orbital region is dependent on the presence of an eye, which stimulates growth of the orbit and proper formation of the lids and the ocular fornices. Commonly, a child born with anophthalmia has a small orbit with narrow palpebral fissure and shrunken fornices.

Epidemiology

Frequency

United States

Congenital anophthalmos is a very rare condition that has a reported prevalence rate of 0.18 per 10,000 births.[3]

International

European rates are similar to those seen in the United States and have been reported as 0.19 case per 10,000 births.[4]

Australian rates are reported as 0.06-0.42 case per 10,000 births and 0.2-1.7 cases per 10,000 births for anophthalmia and microphthalmia, respectively.[5]

Mortality/Morbidity

Growth and development of the bony orbit is directly dependent on outgrowth of the globe.

Lack of an eye or a microphthalmic eye causes improper development of the orbit.

A small bony orbit results in hemifacial hypoplasia and will not allow a prosthesis to be fit. The cosmetic deformity can be quite significant.

Race

Classically, racial predilection for anophthalmos has not been reported; however, recent studies have shown an elevated prevalence in some ethnic groups. These groups include Pakistani and Scottish children. Genetic, environmental, and possible classification issues may explain these high rates of disease and need to be explored further.[6]

Sex

Sexual predilection for congenital anophthalmos has not been reported.

Age

Anophthalmos occurs in utero and is a congenital anomaly that is present at birth.

History

The defect occurs in utero and is congenital. Children with anophthalmos are born with a unilaterally small orbit and no visible ocular tissue within the orbit.[7]

Physical

Physical findings are as follows.[8, 9, 5, 10]

Orbital findings may include the following:

Eyelid findings may include the following:

Globe findings may include the following:

Systemic findings may include the following:

Causes

Causes of anophthalmos include the following:

Imaging Studies

Imaging studies in anophthalmos are as follows.[16]

CT scan or MRI

CT scan or MRI of the head and the orbits is used to assess the presence of an extremely microphthalmic globe

Bilateral anophthalmos may have an associated absence of the optic chiasma, a diminished size of the posterior pathways, as well as agenesis or dysgenesis of the corpus callosum.[16]

Patients with unilateral anophthalmos may have severe craniofacial anomalies that need to be evaluated by scanning.

Ultrasound imaging

B-scan ultrasound will show a complete absence of ocular tissue in anophthalmos.

A-scan ultrasound will show a decreased axial length in microphthalmos.

Transvaginal ultrasound can detect eye malformations after 22 weeks’ gestation; however, its sensitivity for use in the detection of anophthalmia is not known.

Histologic Findings

Primary anophthalmos is characterized by a complete absence of ocular tissue within the orbit. Extreme microphthalmos is seen more commonly. Histopathological evaluation of orbital contents reveals an extremely small or malformed globe with only rudimentary ocular contents. Overall, extraocular muscles often are absent or markedly decreased in anophthalmia.

Medical Care

Medical care in anophthalmos focuses on treating the soft tissue hypoplasia as well as asymmetric bony growth and is as follows.[17, 18, 19]

Ocular/orbital [20]

A solid conformer may be placed in the orbit to stimulate bony orbital growth and to enlarge the orbital cavity in an attempt to attain normal proportions.

Progressively increasing the size of conformers will often help to increase the size of the orbit.

Solid conformers require multiple procedures and are generally unable to keep pace with bony growth of the contralateral normal orbit.

An ocular prosthesis may be fitted over the conformer to improve the appearance.

In patients with unilateral anophthalmos, they and their families should be aware that the target proportions of a reconstructed orbit are not planned to exactly mirror that of a healthy orbit. In all likelihood, a perfectly normal-looking orbit will not be achieved.

Surgical Care

Surgical care in anophthalmos is as follows.[21]

Inflatable expander [22]

If conformers are not tolerated or are unsuccessful, an inflatable expander may be placed surgically.

The expander works best if placed relatively early in life, especially within the first year.

The inflatable silicone expander is placed surgically deep into the orbit and is accessible by a tube placed in the lateral orbital rim.

The expander can be gradually filled with liquid (eg, saline) on a weekly or biweekly basis.

The advantage of an inflatable expander is that it may allow more rapid and extensive orbital tissue expansion as compared with solid conformers.

Integrated orbital tissue expanders have been shown[23] to stimulate orbital bone growth in a feline model.[24]

Recent clinical reports have shown promising results in the stimulation of anophthalmic orbital growth.[25, 26]

Self-expanding hydrophilic, osmotic expanders [27]

A new possible treatment is the use of self-inflating expanders.

Hydrophilic expanders are placed in their dry, contracted state. The expanders then expand gradually to their full size via osmotic absorption of surrounding tissue fluid.

This method offers the benefit of controllable self-expansion, without the necessity of repeated fittings of solid conformers or surgical placement of external tubing required for inflatable expanders.

Long-term biocompatibility studies have not been completed, but early results are promising.

Injectable calcium hydroxylapatite

Volume augmentation in the anophthalmic socket with injectable hydroxylapatite (Radiesse) has been reported.[28]

Eyelid surgery

The increase in the size of a conformer is often limited by shortening of the eyelids in the palpebral fissure, which do not permit passage of a large conformer. The horizontal length of the palpebral fissure may be increased surgically by performing a lateral canthotomy or cantholysis.

An additional method to lengthen the eyelids can be accomplished by a combination of skin, mucosal, or cartilage grafts.

Eyelid reconstruction presents a challenge. In cases of anophthalmia, skin graft is required to construct eyelids. Since the area around the eye is cosmetically important, grafts from areas of the head covered by hairline may be advantageous.[29]

Orbital surgery

If conformers and expanders are unsuccessful, the bony orbit may be expanded surgically. This method is preferred in cases of late referral or insufficient orbital volume.

The orbit can be expanded in 3 different directions, as follows: laterally, inferiorly, and superiorly.

Surgical expansion of the orbit can be accomplished by dividing the bony orbital rim into 3 parts in a stepwise fashion.

Cranial bone grafts may be used to augment deficient orbital contours.

Lastly, a bicoronal approach through the scalp may be necessary when the orbital roof has to be elevated.

A survey of oculofacial surgeons found that silicone and acrylic were the most popular orbital implant materials in both adults and children, followed by porous polyethylene. The mean implant size was 20.2 ± 1.78 mm in adults and 17.2 ± 2.36 mm in the pediatric population.[30]

Consultations

Anophthalmos causes serious psychological problems due to not only the absence of an eye but also the disfigurement of the orbital socket and the eyelids. Psychological counseling or consultation may be warranted for these children.

Complications

Significant cosmetic deformities are often seen if the anophthalmic orbit is not treated early.

Even after proper treatment using conformers, expanders, or surgical treatment, results are often cosmetically disappointing.

Fitted prostheses are completely immobile.

The eyelids often show significant malformations and are shortened and immobile.

Phantom eye syndrome (PES) is defined as any sensation experienced by a patient with anophthalmia or enucleation and may include phantom pain, phantom sensation, and phantom vision.[31] These sensations may be painful and distressful and may lead to decreased quality of life.

Prognosis

True anophthalmos is considered a pediatric ocular emergency.

As the growth and development of the bony orbit are dependent on the growth of the globe, the absence of an eye or an extremely microphthalmic eye impedes the proper development of the orbit.

The small bony cavity not only is a cosmetic deformity but also does not allow proper fitting of a prosthesis.

Even with proper early treatment, results are often disappointing in patients with anophthalmos.

Recent neuroimaging studies found that a significant rewiring of the brain occurs in individuals with early-life blindness. In individuals with anophthalmia or early-life blindness, the superior colliculus is recruited for auditory processing.[32]

Patient Education

Inform the child with anophthalmos as well as the family that the treatment of this condition could be a long and complicated one.

Multiple conformers, expanders, and surgical treatments may be necessary to create an adequate-sized orbital cavity for placement of a proper-fitting prosthesis. In addition, multiple eyelid and conjunctival surgeries may be necessary throughout the child's life.

The National Eye Institute (NEI) maintains a Web page with answers to frequently asked questions and links to resources that patients may find helpful. 

Author

Nick Mamalis, MD, Professor of Ophthalmology, Director of Ocular Pathology, Department of Ophthalmology, John Moran Eye Center, University of Utah School of Medicine; Director, Intermountain Ocular Research Center

Disclosure: Serve(d) as a director, officer, partner, employee, advisor, consultant or trustee for: Anew Optics Inc; Medennium Inc<br/>Received research grant from: ARC Laser Corp; Aaren Scientific Inc; Abbott Medical Optics; Alcon Labs Inc; Allergan; Anew Optics Inc; Bausch & Lomb; Calhoun Vision Inc; ClarVista; Genisphere; HOYA; LensGen; Medennium Inc; Mynosys; Nu-Vue Technologies; Omega; PowerVision; Sharklet.

Coauthor(s)

He Jack Li, Research Fellow in Ophthalmic Pathology, John A Moran Eye Center, University of Utah School of Medicine

Disclosure: Nothing to disclose.

Scott C Cole, MD, MS, Pre-Residency Fellow in Ophthalmic Pathology, Moran Eye Center, University of Utah School of Medicine

Disclosure: Nothing to disclose.

Specialty Editors

Simon K Law, MD, PharmD, Clinical Professor of Health Sciences, Department of Ophthalmology, Jules Stein Eye Institute, University of California, Los Angeles, David Geffen School of Medicine

Disclosure: Nothing to disclose.

Chief Editor

Hampton Roy, Sr, MD, Associate Clinical Professor, Department of Ophthalmology, University of Arkansas for Medical Sciences

Disclosure: Nothing to disclose.

Additional Contributors

Ron W Pelton, MD, PhD, Private Practice, Colorado Springs, Colorado

Disclosure: Nothing to disclose.

Acknowledgements

Andrew James Ollerton, MD Pre-residency Fellow, Ocular Pathology, Moran Eye Center, University of Utah

Andrew James Ollerton, MD is a member of the following medical societies: American Society of Cataract and Refractive Surgery

Disclosure: Nothing to disclose.

References

  1. Mauri L, Franzoni A, Scarcello M, Sala S, Garavelli L, Modugno A, et al. SOX2, OTX2 and PAX6 analysis in subjects with anophthalmia and microphthalmia. Eur J Med Genet. 2015 Feb. 58 (2):66-70. [View Abstract]
  2. Abouzeid H, Favez T, Schmid A, Agosti C, Youssef M, Marzouk I, et al. Mutations in ALDH1A3 represent a frequent cause of microphthalmia/anophthalmia in consanguineous families. Hum Mutat. 2014 Aug. 35 (8):949-53. [View Abstract]
  3. Shaw GM, Carmichael SL, Yang W, Harris JA, Finnell RH, Lammer EJ. Epidemiologic characteristics of anophthalmia and bilateral microphthalmia among 2.5 million births in California, 1989-1997. Am J Med Genet A. 2005 Aug 15. 137(1):36-40. [View Abstract]
  4. Boyd PA, Haeusler M, Barisic I. EUROCAT Report 9: Surveillance of congenital anomalies in Europe 1980-2008. Birth Defects Res A Clin Mol Teratol. 2011 Mar. 91 Suppl 1:S1. [View Abstract]
  5. Skalicky SE, White AJ, Grigg JR, et al. Microphthalmia, anophthalmia, and coloboma and associated ocular and systemic features: understanding the spectrum. JAMA Ophthalmol. 2013 Dec. 131(12):1517-24. [View Abstract]
  6. Shah SP, Taylor AE, Sowden JC, Ragge NK, Russell-Eggitt I, Rahi JS. Anophthalmos, microphthalmos, and typical coloboma in the United Kingdom: a prospective study of incidence and risk. Invest Ophthalmol Vis Sci. 2011 Jan. 52(1):558-64. [View Abstract]
  7. Roy FH, ed. Ocular Differential Diagnosis. 6th ed. Baltimore, MD: Lippincott, Williams & Wilkins; 1997. 263.
  8. Kennedy RE. The effect of early enucleation on the orbit; in animals and humans. Am J Ophthalmol. 1965 Aug. 60:277-306. [View Abstract]
  9. Putterman AM. Ocular socket problems. Waltman SR, Keates RH, Hoyt CS, eds. Surgery of the Eye. New York: Churchill Livingston; 1988. 749-758.
  10. Macchiaroli A, Kelberman D, Auriemma RS, et al. A novel heterozygous SOX2 mutation causing congenital bilateral anophthalmia, hypogonadotropic hypogonadism and growth hormone deficiency. Gene. 2014 Jan 25. 534(2):282-5. [View Abstract]
  11. Ahmad ME, Dada R, Dada T, Kucheria K. 14q(22) deletion in a familial case of anophthalmia with polydactyly. Am J Med Genet A. 2003 Jul 1. 120(1):117-22. [View Abstract]
  12. Hoover-Fong JE, Cai J, Cargile CB, Thomas GH, Patel A, Griffin CA. Facial dysgenesis: a novel facial syndrome with chromosome 7 deletion p15.1-21.1. Am J Med Genet A. 2003 Feb 15. 117A(1):47-56. [View Abstract]
  13. Bakrania P, Robinson DO, Bunyan DJ, et al. SOX2 anophthalmia syndrome: 12 new cases demonstrating broader phenotype and high frequency of large gene deletions. Br J Ophthalmol. 2007 Nov. 91(11):1471-6. [View Abstract]
  14. Bardakjian TM, Schneider A. The genetics of anophthalmia and microphthalmia. Curr Opin Ophthalmol. 2011 Sep. 22(5):309-13. [View Abstract]
  15. Yahyavi M, Abouzeid H, Gawdat G, et al. ALDH1A3 loss of function causes bilateral anophthalmia/microphthalmia and hypoplasia of the optic nerve and optic chiasm. Hum Mol Genet. 2013 Aug 15. 22(16):3250-8. [View Abstract]
  16. Albernaz VS, Castillo M, Hudgins PA, Mukherji SK. Imaging findings in patients with clinical anophthalmos. AJNR Am J Neuroradiol. 1997 Mar. 18(3):555-61. [View Abstract]
  17. Marchac D, Cophignon J, Achard E, Dufourmentel C. Orbital expansion for anophthalmia and micro-orbitism. Plast Reconstr Surg. 1977 Apr. 59(4):486-91. [View Abstract]
  18. Mustarde JE. The orbital rim. Mustarde JC, Jancsous IT, eds. Plastic Surgery in Infancy and Children. Edinburgh: Churchill Livingston; 1988. 150-155.
  19. Tucker SM, Sapp N, Collin R. Orbital expansion of the congenitally anophthalmic socket. Br J Ophthalmol. 1995 Jul. 79(7):667-71. [View Abstract]
  20. Krastinova D, Kelly MB, Mihaylova M. Surgical management of the anophthalmic orbit, part 1: congenital. Plast Reconstr Surg. 2001 Sep 15. 108(4):817-26. [View Abstract]
  21. Quaranta-Leoni FM. Treatment of the anophthalmic socket. Curr Opin Ophthalmol. 2008 Sep. 19(5):422-7. [View Abstract]
  22. Gundlach KK, Guthoff RF, Hingst VH, Schittkowski MP, Bier UC. Expansion of the socket and orbit for congenital clinical anophthalmia. Plast Reconstr Surg. 2005 Oct. 116(5):1214-22. [View Abstract]
  23. Cepela MA, Nunery WR, Martin RT. Stimulation of orbital growth by the use of expandable implants in the anophthalmic cat orbit. Ophthal Plast Reconstr Surg. 1992. 8(3):157-67; discussion 168-9. [View Abstract]
  24. Tse DT, Pinchuk L, Davis S, Falcone SF, Lee W, Acosta AC, et al. Evaluation of an integrated orbital tissue expander in an anophthalmic feline model. Am J Ophthalmol. 2007 Feb. 143(2):317-327. [View Abstract]
  25. Tse DT, Abdulhafez M, Orozco MA, Tse JD, Azab AO, Pinchuk L. Evaluation of an integrated orbital tissue expander in congenital anophthalmos: report of preliminary clinical experience. Am J Ophthalmol. 2011 Mar. 151(3):470-82.e1. [View Abstract]
  26. Quaranta-Leoni FM. Congenital anophthalmia: current concepts in management. Curr Opin Ophthalmol. 2011 Sep. 22(5):380-4. [View Abstract]
  27. Mazzoli RA, Raymond WR 4th, Ainbinder DJ, Hansen EA. Use of self-expanding, hydrophilic osmotic expanders (hydrogel) in the reconstruction of congenital clinical anophthalmos. Curr Opin Ophthalmol. 2004 Oct. 15(5):426-31. [View Abstract]
  28. Kotlus BS, Dryden RM. Correction of anophthalmic enophthalmos with injectable calcium hydroxylapatite (Radiesse). Ophthal Plast Reconstr Surg. 2007 Jul-Aug. 23(4):313-4. [View Abstract]
  29. Tvrdek M, Kozák J. Reconstruction of eyelids with Washio flap in anophthalmia. Acta Chir Plast. 2014. 56 (1-2):20-2. [View Abstract]
  30. Koh V, Chiam N, Sundar G. Survey of common practices among oculofacial surgeons in the Asia-Pacific region: evisceration, enucleation and management of anophthalmic sockets. Orbit. 2014 Dec. 33 (6):477. [View Abstract]
  31. Andreotti AM, Goiato MC, Pellizzer EP, Pesqueira AA, Guiotti AM, Gennari-Filho H, et al. Phantom eye syndrome: a review of the literature. ScientificWorldJournal. 2014. 2014:686493. [View Abstract]
  32. Coullon GS, Jiang F, Fine I, Watkins KE, Bridge H. Subcortical functional reorganization due to early blindness. J Neurophysiol. 2015 Apr 1. 113 (7):2889-99. [View Abstract]

Anophthalmic socket (left eye).

Close-up view of anophthalmic socket (left eye).

Anophthalmic socket (left eye).

Close-up view of anophthalmic socket (left eye).